FSI Stanford Publications

Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Non-Valvular Atrial Fibrillation

Journal Article

Authors
BF Gage
AB Cardinalli
GW Albers
Douglas K. Owens - Stanford University

Published by
Journal of the American Medical Association, Vol. 274, page(s) 1839-1845
1995

Publications of interest

Cost-Effectiveness of Stroke Prophylaxis for Nonvalular Atrial Fibrillation
BF Gage, AB Cardinalli, GW Albers, Douglas K. Owens
Journal of the American Medical Association vol. 275 (1996)
Effect of Stroke and Stroke Prophylaxis with Aspirin or Warfarin Therapy on Quality of Life, The
B.F. Gage, A.B. Cardinalli, Douglas K. Owens
Archives of Internal Medicine vol. 156 (1996)
Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients Who Have Nonvalvular Atrial Fibrillation
B.F. Gage, A.B. Cardinalli, Douglas K. Owens
Stroke vol. 29 (1998)
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis
MD Schleinitz, JP Weiss, Douglas K. Owens, DA Socks
American Journal of Medicine vol. 116, 12 (2004)